The agency is expected to announce new guidance for Pfizer’s vaccine as early as March 2, the Times reported. The FDA would modify the vaccine’s emergency use authorization to say the vaccine could be stored at higher temperatures.
Pfizer submitted data to the FDA Feb. 19 showing it could be safely stored between minus 13 F and 5 F for up to to weeks. It is currently required to be stored at temperatures between minus 112 F and minus 76 F, which requires specialty freezers that can reach the ultralow temperatures.
Authorizing the vaccines to be stored at higher temperatures could expand the number of sites that would be able to administer the shots, since they wouldn’t have to purchase specialty freezers.
More articles on pharmacy:
Lawsuit alleges Icy Hot, Salonpas patches are marketed deceptively
HHS will stop distributing COVID-19 antibody drugs, says they’re no longer in short supply
Pooling leftover COVID-19 vaccine could create thousands of extra doses, pharmacists say
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
